What are the main safety concerns cited by the FDA for Neuralink implants?

Question

Accepted Answer

FDA Cites Major Safety Concerns for Neuralink Implants

The US Food and Drug Administration (FDA) has rejected Neuralink's application for human trials, citing significant safety concerns for potential recipients of the brain implants. These concerns primarily revolve around the device's components and the risks associated with its implantation and removal.
Concerns Regarding Device Components

A key area of the FDA's apprehension involves the lithium battery integrated into the Neuralink device. Furthermore, the agency has raised questions about the potential for the microscopic wires within the implant to migrate from their intended location to other regions of the brain, posing an unforeseen risk.
Risks of Implantation and Removal

Beyond the device's components, the FDA is also focused on the procedures themselves. Specifically, the agency has expressed concerns about the potential for damage to brain tissue that could occur during the process of removing the implant from a patient.
Ongoing Investigations

These safety concerns are compounded by existing investigations into Neuralink's practices. Two separate inquiries are already underway by US authorities, one concerning animal welfare violations and another examining allegations of improper transport of potentially hazardous materials from animal implants.

Reading history

Hide →

This history is cleared when the page is closed.

What are the main safety concerns cited by the FDA for Neuralink implants?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends